Geode Capital Management, LLC Volitionrx LTD Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Geode Capital Management, LLC holds 743,843 shares of VNRX stock, worth $409,113. This represents 0.0% of its overall portfolio holdings.
Number of Shares
743,843
Previous 730,448
1.83%
Holding current value
$409,113
Previous $438,000
1.83%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding VNRX
# of Institutions
31Shares Held
18.9MCall Options Held
21KPut Options Held
0-
Armistice Capital, LLC New York, NY8.48MShares$4.67 Million0.07% of portfolio
-
Lagoda Investment Management, L.P. New York, NY7.58MShares$4.17 Million2.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$350,1660.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$283,8400.0% of portfolio
-
Cowen Prime Advisors LLC179KShares$98,3050.09% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $31.5M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...